Heartflow Inc. Common Stock vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Heartflow Inc. Common Stock trades at $49.44 (market cap $4.38B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B). The key difference: Heartflow Inc. Common Stock and Indivior Pharmaceuticals Inc. Common Stock are close in size by market cap, and Heartflow Inc. Common Stock is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heartflow Inc. Common Stock for 0 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| HTFL | INDV | |
|---|---|---|
Market Cap | $4.38B | $4.18B |
Volume | 1,454,420 | 1,819,746 |
Sector | Health | Health |
52-Week High | $52.21 | $41.83 |
52-Week Low | $20.49 | $24.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.24B | $4.47B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HeartFlow, Inc. develops AI-powered software that analyzes coronary CT angiography scans to build personalized 3D heart models for coronary artery disease diagnosis, including its FFRct Analysis, Plaque Analysis, and Roadmap Analysis tools.
Read more on HTFL →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →